These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The use of radioiodinated toluidine blue for preoperative localization of parathyroid pathology. Czerniak A; Zwas ST; Shustik O; Avigad I; Ayalon A; Dolev E Surgery; 1991 Nov; 110(5):832-8. PubMed ID: 1948652 [TBL] [Abstract][Full Text] [Related]
26. Paradoxical technetium-thallium subtraction scan in a case of parathyroid adenoma. Bedig G; Sarfati E; Valensi P; Tellier P; Paycha F; Vulpillat M Eur J Nucl Med; 1985; 11(8):324-6. PubMed ID: 3908110 [TBL] [Abstract][Full Text] [Related]
27. New perspectives in localizing enlarged parathyroids by technetium-thallium subtraction scan. Ferlin G; Borsato N; Camerani M; Conte N; Zotti D J Nucl Med; 1983 May; 24(5):438-41. PubMed ID: 6842292 [TBL] [Abstract][Full Text] [Related]
28. Improvement of parathyroid Tl-Tc scintigraphy by using a new image subtraction method. Liehn JC; Amico S; Delisle MJ; Flament JB Eur J Nucl Med; 1988; 14(4):184-9. PubMed ID: 2844539 [TBL] [Abstract][Full Text] [Related]
29. [Diagnostic imaging using 201Tl and 99mTc-pertechnetate in hyperparathyroidism]. Gimlette TM; Brownless SM Med Radiol (Mosk); 1989 May; 34(5):32-44. PubMed ID: 2542714 [No Abstract] [Full Text] [Related]
30. The role of dual radionuclide scintigraphy in the preoperative localization of abnormal parathyroid glands. Opelka FG; Brigham RA; Davies RS; Kaplan KA Am Surg; 1988 Apr; 54(4):240-2. PubMed ID: 3355024 [TBL] [Abstract][Full Text] [Related]
31. The efficacy of technetium-99m-MIBI scan and intraoperative methylene blue staining for the localization of abnormal parathyroid glands. Takei H; Iino Y; Endo K; Horiguchi J; Maemura M; Koibuchi Y; Horii Y; Yokoe T; Ishida T; Oyama T; Morishita Y Surg Today; 1999; 29(4):307-12. PubMed ID: 10211559 [TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Wei JP; Burke GJ; Mansberger AR Surgery; 1992 Dec; 112(6):1111-6; discussion 1116-7. PubMed ID: 1455313 [TBL] [Abstract][Full Text] [Related]
33. Assessment of thallium-pertechnetate subtraction scintigraphy in hyperparathyroidism. Percival RC; Blake GM; Urwin GH; Talbot CH; Williams JL; Kanis JA Br J Radiol; 1985 Feb; 58(686):131-5. PubMed ID: 2998531 [TBL] [Abstract][Full Text] [Related]
34. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. Johnston LB; Carroll MJ; Britton KE; Lowe DG; Shand W; Besser GM; Grossman AB J Clin Endocrinol Metab; 1996 Jan; 81(1):346-52. PubMed ID: 8550776 [TBL] [Abstract][Full Text] [Related]
35. Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging. Lee VS; Wilkinson RH; Leight GS; Coogan AC; Coleman RE Radiology; 1995 Dec; 197(3):627-33. PubMed ID: 7480730 [TBL] [Abstract][Full Text] [Related]
36. Impact on surgery of preoperative localization of parathyroid lesions with dual radionuclide subtraction scanning. Mattar AG; Wright ES; Chittal SM; Kennedy CG; Kwan AH Can J Surg; 1986 Jan; 29(1):57-9. PubMed ID: 3000568 [TBL] [Abstract][Full Text] [Related]